Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Inflammatory Bowel Diseases

  Free Subscription


14.09.2026

3 Aliment Pharmacol Ther
1 Clin Gastroenterol Hepatol
1 Dig Dis
5 Dig Dis Sci
1 Gastroenterology
2 Inflamm Bowel Dis
1 J Clin Gastroenterol
4 J Crohns Colitis
1 Lancet Gastroenterol Hepatol
1 PLoS One
2 Scand J Gastroenterol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. BARBERIO B, D'Amico F, Laterza L, Bezzio C, et al
    Real-World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease-A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).
    Aliment Pharmacol Ther. 2026 Sep 10. doi: 10.1111/apt.70970.
    PubMed         Abstract available

  2. ETCHEGARAY A, Radford-Smith G, Walker G, Croft A, et al
    Letter: Acute Severe Ulcerative Colitis in the Advanced Therapy Era: Is Lowering the CRP Threshold Enough? Authors' Reply.
    Aliment Pharmacol Ther. 2026 Sep 6. doi: 10.1111/apt.70962.
    PubMed        

  3. SATTAYALERTYANYONG O, Nugent Z, Bernstein CN
    Letter: Clarifying the Interpretation of Dialysis Risk in Inflammatory Bowel Disease. Authors' Reply.
    Aliment Pharmacol Ther. 2026 Sep 5. doi: 10.1111/apt.70957.
    PubMed        


    Clin Gastroenterol Hepatol

  4. MAK JWY, Ho AHY, Chan AKW, Miao Y, et al
    Influence of socioeconomic development on incidence and disease phenotype in inflammatory bowel disease: a population-based incident study across 16 regions.
    Clin Gastroenterol Hepatol. 2026 Sep 8:S1542-3565(26)00670.
    PubMed         Abstract available


    Dig Dis

  5. HORII T, Ikehara H, Harada Y, Fukagawa N, et al
    Pretreatment Histopathological Features are Associated with Ustekinumab Efficacy in Ulcerative Colitis: A Retrospective Pilot Study.
    Dig Dis. 2026 Sep 7:1. doi: 10.1159.
    PubMed         Abstract available


    Dig Dis Sci

  6. VAN DE POL N, Paulides E, Wolfhagen FHJ, West RL, et al
    Low-Dose Naltrexone in Crohn's Disease: A Prematurely Terminated Randomized Trial Showing Reduced Fatigue Without Clinical or Endoscopic Benefit.
    Dig Dis Sci. 2026 Sep 6. doi: 10.1007/s10620-026-10234.
    PubMed         Abstract available

  7. DENTON KH, Slaughter JC, Bennett A, Scoville EA, et al
    Patient Perspectives of Intestinal Ultrasound in IBD: A Quantitative Evaluation of Satisfaction and Diagnostic Preference.
    Dig Dis Sci. 2026;71:5063-5070.
    PubMed         Abstract available

  8. SHON WJ, Kim KA, Kim JS, Kim BG, et al
    Habitual Ultra-processed Food Intake Is Associated with Gut Dysbiosis and Pro-inflammatory Metabolite Profiles in Korean Patients with IBD.
    Dig Dis Sci. 2026;71:4967-4983.
    PubMed         Abstract available

  9. INGABIRE CG, Battat R, Rex DK, Daoud DC, et al
    Sporadic Adenoma Detection During Routine IBD Colonoscopies: A Secondary Analysis of Prospectively Collected Data.
    Dig Dis Sci. 2026;71:4894-4903.
    PubMed         Abstract available

  10. SEGUN-OMOSEHIN O, Bourdakos NE, Tzanis KG, Macaron MM, et al
    Pairwise Comparative Safety and Effectiveness of Anti-TNF Blockers, Vedolizumab, and Ustekinumab During Pregnancy: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2026;71:5200-5212.
    PubMed         Abstract available


    Gastroenterology

  11. GRANNO O, Bergemalm D, Salomon B, Hoivik ML, et al
    Increased Perinatal Levels of Chemokine (C-X-C Motif) Ligand 9, Granzyme B, and Matrix Metalloproteinase-10 Are Associated With Pediatric-Onset Inflammatory Bowel Disease: A Nested Case-Control Study Within a Population-Based Birth Cohort.
    Gastroenterology. 2026 Aug 27:S0016-5085(26)07182.
    PubMed        


    Inflamm Bowel Dis

  12. DAPKE K, Desai A
    Reply: "Appendectomy before or after ulcerative colitis and the long-term outcomes".
    Inflamm Bowel Dis. 2026 Sep 5:izag180. doi: 10.1093.
    PubMed        

  13. THANGARAJAH D, Chappell K, Burtt AH, Frost G, et al
    Defining adipose tissue profiles in children with Crohn's disease.
    Inflamm Bowel Dis. 2026 Sep 11:izag174. doi: 10.1093.
    PubMed         Abstract available


    J Clin Gastroenterol

  14. KIM JE, Hong SN, Kim ER, Chang DK, et al
    Pharmacokinetic Predictor of Infection in Patients With Inflammatory Bowel Disease Treated With Intravenous and Subcutaneous Infliximab.
    J Clin Gastroenterol. 2026 Sep 11. doi: 10.1097/MCG.0000000000002431.
    PubMed         Abstract available


    J Crohns Colitis

  15. YEH PJ, Charlesworth JEG, Taylor H, Ashton JJ, et al
    A therapeutic atlas of monogenic inflammatory bowel disease.
    J Crohns Colitis. 2026;20:jjag124.
    PubMed         Abstract available

  16. GIORIO L, De Vos S, Colli ML, Merciris D, et al
    Bridging preclinical and clinical efficacy of SIK2/SIK3 inhibition in inflammatory bowel disease through integrated murine, patient-derived models, and phase 2a trial-based analyses.
    J Crohns Colitis. 2026;20:jjag133.
    PubMed         Abstract available

  17. BASNAYAKE K, Subhaharan D, Drobne D, Deepak P, et al
    Isolated perianal fistulizing Crohn's disease in contemporary clinical practice: a multicenter ECCO-CONFER cohort study.
    J Crohns Colitis. 2026;20:jjag130.
    PubMed         Abstract available

  18. TRUYENS M, Tolstoy X, Calabrese G, Cremer A, et al
    Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease.
    J Crohns Colitis. 2026;20:jjag129.
    PubMed         Abstract available


    Lancet Gastroenterol Hepatol

  19. NOOR NM, Sharip MT, Zheng H, Widmer B, et al
    Long-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn's disease: 5-year follow-up of the PROFILE trial.
    Lancet Gastroenterol Hepatol. 2026 Sep 10:S2468-1253(26)00192.
    PubMed         Abstract available


    PLoS One

  20. XU W, Ji A, Han L, Xiong H, et al
    From gut to pancreas: Shared genetic susceptibility and biological convergence in acute pancreatitis and Crohn's disease.
    PLoS One. 2026;21:e0353031.
    PubMed         Abstract available


    Scand J Gastroenterol

  21. ILVEMARK JFKF, Christensen KR, Steenholdt C, Brynskov J, et al
    Intestinal ultrasound: a non-invasive alternative to monitor and predict biologic treatment persistence in patients with inflammatory bowel disease.
    Scand J Gastroenterol. 2026 Sep 11:1-10. doi: 10.1080/00365521.2026.2727539.
    PubMed         Abstract available

  22. EJSING JG, Jensen MD, Jorgensen MT
    Autoimmune pancreatitis type 2 and its relationship with inflammatory bowel disease: a narrative review.
    Scand J Gastroenterol. 2026 Sep 10:1-10. doi: 10.1080/00365521.2026.2724329.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum